French healthcare nonprofit Médecins Sans Frontières (MSF) has called on European lawmakers to amend a proposed law which would result in an effective export ba 16 January 2024
Belgium’s UCB (Euronext: UCB) has won European Commission (EC) approval for Rystiggo (rozanolixizumab) as an add-on to standard therapy for generalized myasthen 8 January 2024
Last month, the European Commission (EC) approved Ebglyss (lebrikizumab) for the treatment of adult and adolescent patients with moderate-to-severe atopic derma 21 December 2023
The European Commission (EC), the Heads of Medicines Agencies (HMA) and the European Medicines Agency (EMA) have published the first version of the Union list o 12 December 2023
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.